Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve the Audited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Remedium Lifecare Ltd (formerly Roxy Exports Limited, Scrip Code: 539561) has informed BSE that its Board of Directors will meet on Friday, May 30, 2025, to consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2025. The filing is made under Regulation 29 of the SEBI (LODR) Regulations, 2015. The company's trading window for insiders, which closed on April 1, 2025, will remain closed until 48 hours after the audited results are declared. No actual financial figures or operational details have been disclosed in this intimation, which is a routine pre-results announcement.
This is a standard procedural notice with no immediate impact on shareholders. Investors should watch for the actual audited FY25 results announcement after May 30 for any meaningful data on the company's full-year performance.